What are the key drivers for selecting ideal RRMM patients for treatment with CAR T-cell therapy?
After participating in this webinar, viewers should be able to:
- Explain what the key drivers are when selecting RRMM patients for treatment with CAR T-cell therapy
- Michel Delforge (Belgium)
- Joaquin Martinez-Lopez (Spain)
- Herman Einsele (Germany)